(Q43299685)
Statements
A phase II study of 5-day intravenous azacitidine in patients with myelodysplastic syndromes (English)
Amanda F Cashen
Camille N Abboud
Keith Stockerl-Goldstein
Mike G Martin
Richard A Walgren
Elizabeth Procknow
Peter Westervelt
Frederieke Kreisel
Kristan Augustin
John F Dipersio
1 September 2009